TABLE 4.
Patient group
|
|||
---|---|---|---|
Below target LDL-C (n=674) | Above target LDL-C (n=163) | P | |
LDL-C, mmol/L (mean ± SD) | |||
Baseline | 3.28±0.70 | 4.03±1.12 | 0.001* |
Six weeks | 2.13±0.57 | 3.46±1.07 | 0.001* |
Change in LDL-C, % (mean ± SD) | |||
Baseline to six weeks | −34.10±15.86 | −12.47±18.39 | 0.001* |
P | 0.001† | 0.001† | |
Statin dose at baseline, n (%) | |||
10 mg/day | 168 (24.9) | 28 (17.2) | 0.005‡ |
20 mg/day | 253 (37.5) | 52 (31.9) | |
40 mg/day – 80 mg/day | 261 (38.7) | 86 (52.8) | |
10-year coronary artery disease risk, n (%) | |||
Low | 623 (92.4) | 154 (94.5) | 0.825‡ |
Moderate | 34 (5.0) | 6 (3.7) | |
High | 17 (2.5) | 3 (1.8) |
P value based on Student’s t test for independent groups;
†P value based on Student’s t test for paired comparisons;
P value based on χ2 test